nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP2C8—Spironolactone—dilated cardiomyopathy	0.202	0.409	CbGbCtD
Omeprazole—ABCB1—Lisinopril—dilated cardiomyopathy	0.155	0.314	CbGbCtD
Omeprazole—ABCB1—Spironolactone—dilated cardiomyopathy	0.137	0.277	CbGbCtD
Omeprazole—ATP4B—Ion transport by P-type ATPases—PLN—dilated cardiomyopathy	0.00506	0.12	CbGpPWpGaD
Omeprazole—Eruption—Furosemide—dilated cardiomyopathy	0.00504	0.0109	CcSEcCtD
Omeprazole—Leg pain—Lisinopril—dilated cardiomyopathy	0.00504	0.0109	CcSEcCtD
Omeprazole—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.00488	0.0105	CcSEcCtD
Omeprazole—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.00459	0.00989	CcSEcCtD
Omeprazole—ATP4A—Ion transport by P-type ATPases—PLN—dilated cardiomyopathy	0.00451	0.107	CbGpPWpGaD
Omeprazole—Apathy—Furosemide—dilated cardiomyopathy	0.00434	0.00935	CcSEcCtD
Omeprazole—Flat affect—Furosemide—dilated cardiomyopathy	0.0043	0.00926	CcSEcCtD
Omeprazole—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00415	0.00894	CcSEcCtD
Omeprazole—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00405	0.00872	CcSEcCtD
Omeprazole—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.00391	0.00842	CcSEcCtD
Omeprazole—Glycosuria—Furosemide—dilated cardiomyopathy	0.00382	0.00824	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00372	0.00802	CcSEcCtD
Omeprazole—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00372	0.00802	CcSEcCtD
Omeprazole—Gastritis—Spironolactone—dilated cardiomyopathy	0.00366	0.00788	CcSEcCtD
Omeprazole—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.00362	0.0078	CcSEcCtD
Omeprazole—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.00338	0.00729	CcSEcCtD
Omeprazole—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00334	0.0072	CcSEcCtD
Omeprazole—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00329	0.00709	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00316	0.00681	CcSEcCtD
Omeprazole—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00316	0.0068	CcSEcCtD
Omeprazole—Renal failure—Spironolactone—dilated cardiomyopathy	0.00313	0.00675	CcSEcCtD
Omeprazole—Otitis media—Lisinopril—dilated cardiomyopathy	0.00299	0.00643	CcSEcCtD
Omeprazole—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00297	0.00641	CcSEcCtD
Omeprazole—Urine output increased—Furosemide—dilated cardiomyopathy	0.0028	0.00604	CcSEcCtD
Omeprazole—Bladder pain—Furosemide—dilated cardiomyopathy	0.0028	0.00604	CcSEcCtD
Omeprazole—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00277	0.00597	CcSEcCtD
Omeprazole—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.0027	0.00583	CcSEcCtD
Omeprazole—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00265	0.0057	CcSEcCtD
Omeprazole—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00263	0.00566	CcSEcCtD
Omeprazole—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00261	0.00562	CcSEcCtD
Omeprazole—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00256	0.00552	CcSEcCtD
Omeprazole—Polyuria—Furosemide—dilated cardiomyopathy	0.00256	0.00552	CcSEcCtD
Omeprazole—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00256	0.00551	CcSEcCtD
Omeprazole—Swelling—Furosemide—dilated cardiomyopathy	0.00255	0.00549	CcSEcCtD
Omeprazole—Alopecia—Spironolactone—dilated cardiomyopathy	0.00253	0.00545	CcSEcCtD
Omeprazole—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00251	0.00542	CcSEcCtD
Omeprazole—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00249	0.00537	CcSEcCtD
Omeprazole—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00247	0.00533	CcSEcCtD
Omeprazole—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00244	0.00526	CcSEcCtD
Omeprazole—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00239	0.00516	CcSEcCtD
Omeprazole—Thirst—Furosemide—dilated cardiomyopathy	0.00236	0.00509	CcSEcCtD
Omeprazole—Purpura—Furosemide—dilated cardiomyopathy	0.00233	0.00503	CcSEcCtD
Omeprazole—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00231	0.00498	CcSEcCtD
Omeprazole—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00227	0.00489	CcSEcCtD
Omeprazole—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00226	0.00487	CcSEcCtD
Omeprazole—Malaise—Spironolactone—dilated cardiomyopathy	0.00225	0.00484	CcSEcCtD
Omeprazole—Cystitis—Lisinopril—dilated cardiomyopathy	0.00224	0.00484	CcSEcCtD
Omeprazole—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00223	0.0048	CcSEcCtD
Omeprazole—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00221	0.00476	CcSEcCtD
Omeprazole—Irritability—Furosemide—dilated cardiomyopathy	0.00215	0.00463	CcSEcCtD
Omeprazole—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00211	0.00454	CcSEcCtD
Omeprazole—Bladder pain—Lisinopril—dilated cardiomyopathy	0.0021	0.00453	CcSEcCtD
Omeprazole—Discomfort—Spironolactone—dilated cardiomyopathy	0.00209	0.00451	CcSEcCtD
Omeprazole—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00208	0.00448	CcSEcCtD
Omeprazole—Confusional state—Spironolactone—dilated cardiomyopathy	0.00205	0.00441	CcSEcCtD
Omeprazole—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00205	0.00441	CcSEcCtD
Omeprazole—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00204	0.00439	CcSEcCtD
Omeprazole—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00203	0.00438	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00203	0.00436	CcSEcCtD
Omeprazole—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00203	0.00436	CcSEcCtD
Omeprazole—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00199	0.00429	CcSEcCtD
Omeprazole—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00198	0.00427	CcSEcCtD
Omeprazole—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00196	0.00422	CcSEcCtD
Omeprazole—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00195	0.0042	CcSEcCtD
Omeprazole—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00193	0.00416	CcSEcCtD
Omeprazole—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00192	0.00414	CcSEcCtD
Omeprazole—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00191	0.00411	CcSEcCtD
Omeprazole—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.0019	0.0041	CcSEcCtD
Omeprazole—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00188	0.00405	CcSEcCtD
Omeprazole—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00187	0.00403	CcSEcCtD
Omeprazole—Injury—Lisinopril—dilated cardiomyopathy	0.00184	0.00396	CcSEcCtD
Omeprazole—Somnolence—Spironolactone—dilated cardiomyopathy	0.00181	0.00389	CcSEcCtD
Omeprazole—ATP4B—Ion channel transport—RYR2—dilated cardiomyopathy	0.0018	0.0426	CbGpPWpGaD
Omeprazole—Pollakiuria—Furosemide—dilated cardiomyopathy	0.0018	0.00387	CcSEcCtD
Omeprazole—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00177	0.00382	CcSEcCtD
Omeprazole—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00177	0.00382	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00175	0.00378	CcSEcCtD
Omeprazole—ATP4B—Ion channel transport—PLN—dilated cardiomyopathy	0.00175	0.0415	CbGpPWpGaD
Omeprazole—Arthritis—Lisinopril—dilated cardiomyopathy	0.00174	0.00374	CcSEcCtD
Omeprazole—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00173	0.00373	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00172	0.0037	CcSEcCtD
Omeprazole—Renal failure—Furosemide—dilated cardiomyopathy	0.0017	0.00367	CcSEcCtD
Omeprazole—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00169	0.00365	CcSEcCtD
Omeprazole—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00169	0.00364	CcSEcCtD
Omeprazole—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00169	0.00364	CcSEcCtD
Omeprazole—Diplopia—Lisinopril—dilated cardiomyopathy	0.00169	0.00364	CcSEcCtD
Omeprazole—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00167	0.00361	CcSEcCtD
Omeprazole—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00164	0.00353	CcSEcCtD
Omeprazole—ABCC3—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00163	0.0387	CbGpPWpGaD
Omeprazole—Face oedema—Lisinopril—dilated cardiomyopathy	0.00163	0.00351	CcSEcCtD
Omeprazole—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00162	0.00349	CcSEcCtD
Omeprazole—Urticaria—Spironolactone—dilated cardiomyopathy	0.00161	0.00348	CcSEcCtD
Omeprazole—Irritability—Lisinopril—dilated cardiomyopathy	0.00161	0.00347	CcSEcCtD
Omeprazole—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00161	0.00346	CcSEcCtD
Omeprazole—ATP4A—Ion channel transport—RYR2—dilated cardiomyopathy	0.0016	0.038	CbGpPWpGaD
Omeprazole—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00158	0.00341	CcSEcCtD
Omeprazole—ATP4A—Ion channel transport—PLN—dilated cardiomyopathy	0.00156	0.037	CbGpPWpGaD
Omeprazole—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00154	0.00331	CcSEcCtD
Omeprazole—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00153	0.00329	CcSEcCtD
Omeprazole—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00152	0.00329	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00152	0.00327	CcSEcCtD
Omeprazole—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00152	0.00327	CcSEcCtD
Omeprazole—Visual impairment—Furosemide—dilated cardiomyopathy	0.0015	0.00323	CcSEcCtD
Omeprazole—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0015	0.00323	CcSEcCtD
Omeprazole—Gastritis—Lisinopril—dilated cardiomyopathy	0.00149	0.00322	CcSEcCtD
Omeprazole—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00147	0.00317	CcSEcCtD
Omeprazole—Asthma—Lisinopril—dilated cardiomyopathy	0.00146	0.00314	CcSEcCtD
Omeprazole—Influenza—Lisinopril—dilated cardiomyopathy	0.00146	0.00314	CcSEcCtD
Omeprazole—Eye disorder—Furosemide—dilated cardiomyopathy	0.00145	0.00313	CcSEcCtD
Omeprazole—Tinnitus—Furosemide—dilated cardiomyopathy	0.00145	0.00313	CcSEcCtD
Omeprazole—Pruritus—Spironolactone—dilated cardiomyopathy	0.00144	0.0031	CcSEcCtD
Omeprazole—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00143	0.00309	CcSEcCtD
Omeprazole—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00143	0.00308	CcSEcCtD
Omeprazole—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00142	0.00306	CcSEcCtD
Omeprazole—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00142	0.00306	CcSEcCtD
Omeprazole—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00141	0.00303	CcSEcCtD
Omeprazole—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00139	0.003	CcSEcCtD
Omeprazole—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00139	0.00298	CcSEcCtD
Omeprazole—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00136	0.00294	CcSEcCtD
Omeprazole—Dysuria—Lisinopril—dilated cardiomyopathy	0.00136	0.00294	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00136	0.00292	CcSEcCtD
Omeprazole—Malnutrition—Furosemide—dilated cardiomyopathy	0.00135	0.00292	CcSEcCtD
Omeprazole—Dizziness—Spironolactone—dilated cardiomyopathy	0.00134	0.0029	CcSEcCtD
Omeprazole—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00134	0.00289	CcSEcCtD
Omeprazole—Flatulence—Furosemide—dilated cardiomyopathy	0.00133	0.00288	CcSEcCtD
Omeprazole—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00133	0.00287	CcSEcCtD
Omeprazole—Weight increased—Lisinopril—dilated cardiomyopathy	0.00133	0.00286	CcSEcCtD
Omeprazole—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00133	0.00286	CcSEcCtD
Omeprazole—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00132	0.00284	CcSEcCtD
Omeprazole—Muscle spasms—Furosemide—dilated cardiomyopathy	0.0013	0.00281	CcSEcCtD
Omeprazole—Depression—Lisinopril—dilated cardiomyopathy	0.0013	0.00279	CcSEcCtD
Omeprazole—Vomiting—Spironolactone—dilated cardiomyopathy	0.00129	0.00278	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00129	0.00278	CcSEcCtD
Omeprazole—Rash—Spironolactone—dilated cardiomyopathy	0.00128	0.00276	CcSEcCtD
Omeprazole—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00128	0.00276	CcSEcCtD
Omeprazole—Renal failure—Lisinopril—dilated cardiomyopathy	0.00128	0.00275	CcSEcCtD
Omeprazole—Vision blurred—Furosemide—dilated cardiomyopathy	0.00128	0.00275	CcSEcCtD
Omeprazole—Headache—Spironolactone—dilated cardiomyopathy	0.00127	0.00274	CcSEcCtD
Omeprazole—Jaundice—Lisinopril—dilated cardiomyopathy	0.00127	0.00273	CcSEcCtD
Omeprazole—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00126	0.00272	CcSEcCtD
Omeprazole—Anaemia—Furosemide—dilated cardiomyopathy	0.00125	0.0027	CcSEcCtD
Omeprazole—Agitation—Furosemide—dilated cardiomyopathy	0.00124	0.00268	CcSEcCtD
Omeprazole—Haematuria—Lisinopril—dilated cardiomyopathy	0.00124	0.00267	CcSEcCtD
Omeprazole—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00123	0.00265	CcSEcCtD
Omeprazole—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00123	0.00264	CcSEcCtD
Omeprazole—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00122	0.00263	CcSEcCtD
Omeprazole—Vertigo—Furosemide—dilated cardiomyopathy	0.00122	0.00262	CcSEcCtD
Omeprazole—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00121	0.00262	CcSEcCtD
Omeprazole—Leukopenia—Furosemide—dilated cardiomyopathy	0.00121	0.00261	CcSEcCtD
Omeprazole—Nausea—Spironolactone—dilated cardiomyopathy	0.00121	0.0026	CcSEcCtD
Omeprazole—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00119	0.00256	CcSEcCtD
Omeprazole—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00117	0.00252	CcSEcCtD
Omeprazole—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00117	0.00252	CcSEcCtD
Omeprazole—Hallucination—Lisinopril—dilated cardiomyopathy	0.00116	0.0025	CcSEcCtD
Omeprazole—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00116	0.0025	CcSEcCtD
Omeprazole—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00115	0.00248	CcSEcCtD
Omeprazole—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00115	0.00248	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00115	0.00247	CcSEcCtD
Omeprazole—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00114	0.00247	CcSEcCtD
Omeprazole—Dry mouth—Furosemide—dilated cardiomyopathy	0.00113	0.00243	CcSEcCtD
Omeprazole—Confusional state—Furosemide—dilated cardiomyopathy	0.00111	0.0024	CcSEcCtD
Omeprazole—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00111	0.00238	CcSEcCtD
Omeprazole—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.0011	0.00238	CcSEcCtD
Omeprazole—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00109	0.00235	CcSEcCtD
Omeprazole—Shock—Furosemide—dilated cardiomyopathy	0.00109	0.00234	CcSEcCtD
Omeprazole—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00108	0.00234	CcSEcCtD
Omeprazole—Flushing—Lisinopril—dilated cardiomyopathy	0.00108	0.00233	CcSEcCtD
Omeprazole—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00108	0.00233	CcSEcCtD
Omeprazole—Skin disorder—Furosemide—dilated cardiomyopathy	0.00107	0.00231	CcSEcCtD
Omeprazole—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00107	0.0023	CcSEcCtD
Omeprazole—Anorexia—Furosemide—dilated cardiomyopathy	0.00105	0.00227	CcSEcCtD
Omeprazole—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00105	0.00227	CcSEcCtD
Omeprazole—Chills—Lisinopril—dilated cardiomyopathy	0.00105	0.00226	CcSEcCtD
Omeprazole—Alopecia—Lisinopril—dilated cardiomyopathy	0.00103	0.00222	CcSEcCtD
Omeprazole—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00102	0.0022	CcSEcCtD
Omeprazole—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00102	0.00219	CcSEcCtD
Omeprazole—Flatulence—Lisinopril—dilated cardiomyopathy	0.001	0.00216	CcSEcCtD
Omeprazole—Tension—Lisinopril—dilated cardiomyopathy	0.000997	0.00215	CcSEcCtD
Omeprazole—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000995	0.00214	CcSEcCtD
Omeprazole—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000993	0.00214	CcSEcCtD
Omeprazole—Nervousness—Lisinopril—dilated cardiomyopathy	0.000987	0.00213	CcSEcCtD
Omeprazole—Back pain—Lisinopril—dilated cardiomyopathy	0.000983	0.00212	CcSEcCtD
Omeprazole—Somnolence—Furosemide—dilated cardiomyopathy	0.000983	0.00212	CcSEcCtD
Omeprazole—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000977	0.00211	CcSEcCtD
Omeprazole—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000961	0.00207	CcSEcCtD
Omeprazole—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000958	0.00206	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000954	0.00206	CcSEcCtD
Omeprazole—Fatigue—Furosemide—dilated cardiomyopathy	0.000953	0.00205	CcSEcCtD
Omeprazole—Tremor—Lisinopril—dilated cardiomyopathy	0.000952	0.00205	CcSEcCtD
Omeprazole—Constipation—Furosemide—dilated cardiomyopathy	0.000945	0.00204	CcSEcCtD
Omeprazole—Pain—Furosemide—dilated cardiomyopathy	0.000945	0.00204	CcSEcCtD
Omeprazole—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000943	0.00203	CcSEcCtD
Omeprazole—Anaemia—Lisinopril—dilated cardiomyopathy	0.000939	0.00202	CcSEcCtD
Omeprazole—Angioedema—Lisinopril—dilated cardiomyopathy	0.000929	0.002	CcSEcCtD
Omeprazole—Malaise—Lisinopril—dilated cardiomyopathy	0.000916	0.00197	CcSEcCtD
Omeprazole—Vertigo—Lisinopril—dilated cardiomyopathy	0.000913	0.00197	CcSEcCtD
Omeprazole—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000911	0.00196	CcSEcCtD
Omeprazole—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00091	0.00196	CcSEcCtD
Omeprazole—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000904	0.00195	CcSEcCtD
Omeprazole—Palpitations—Lisinopril—dilated cardiomyopathy	0.000898	0.00194	CcSEcCtD
Omeprazole—Cough—Lisinopril—dilated cardiomyopathy	0.000887	0.00191	CcSEcCtD
Omeprazole—Urticaria—Furosemide—dilated cardiomyopathy	0.000878	0.00189	CcSEcCtD
Omeprazole—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000874	0.00188	CcSEcCtD
Omeprazole—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000874	0.00188	CcSEcCtD
Omeprazole—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000865	0.00186	CcSEcCtD
Omeprazole—Chest pain—Lisinopril—dilated cardiomyopathy	0.000865	0.00186	CcSEcCtD
Omeprazole—Myalgia—Lisinopril—dilated cardiomyopathy	0.000865	0.00186	CcSEcCtD
Omeprazole—Anxiety—Lisinopril—dilated cardiomyopathy	0.000862	0.00186	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000859	0.00185	CcSEcCtD
Omeprazole—Discomfort—Lisinopril—dilated cardiomyopathy	0.000855	0.00184	CcSEcCtD
Omeprazole—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000846	0.00182	CcSEcCtD
Omeprazole—Confusional state—Lisinopril—dilated cardiomyopathy	0.000836	0.0018	CcSEcCtD
Omeprazole—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000829	0.00179	CcSEcCtD
Omeprazole—Infection—Lisinopril—dilated cardiomyopathy	0.000824	0.00178	CcSEcCtD
Omeprazole—Shock—Lisinopril—dilated cardiomyopathy	0.000816	0.00176	CcSEcCtD
Omeprazole—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000814	0.00176	CcSEcCtD
Omeprazole—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000812	0.00175	CcSEcCtD
Omeprazole—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000809	0.00174	CcSEcCtD
Omeprazole—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000806	0.00174	CcSEcCtD
Omeprazole—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000802	0.00173	CcSEcCtD
Omeprazole—Asthenia—Furosemide—dilated cardiomyopathy	0.000793	0.00171	CcSEcCtD
Omeprazole—Anorexia—Lisinopril—dilated cardiomyopathy	0.000791	0.0017	CcSEcCtD
Omeprazole—Pruritus—Furosemide—dilated cardiomyopathy	0.000782	0.00169	CcSEcCtD
Omeprazole—CYP1B1—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00077	0.0183	CbGpPWpGaD
Omeprazole—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000756	0.00163	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000756	0.00163	CcSEcCtD
Omeprazole—Insomnia—Lisinopril—dilated cardiomyopathy	0.00075	0.00162	CcSEcCtD
Omeprazole—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000745	0.0016	CcSEcCtD
Omeprazole—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000739	0.00159	CcSEcCtD
Omeprazole—Somnolence—Lisinopril—dilated cardiomyopathy	0.000737	0.00159	CcSEcCtD
Omeprazole—Dizziness—Furosemide—dilated cardiomyopathy	0.000731	0.00158	CcSEcCtD
Omeprazole—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00073	0.00157	CcSEcCtD
Omeprazole—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000721	0.00155	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000716	0.00154	CcSEcCtD
Omeprazole—Fatigue—Lisinopril—dilated cardiomyopathy	0.000715	0.00154	CcSEcCtD
Omeprazole—Pain—Lisinopril—dilated cardiomyopathy	0.000709	0.00153	CcSEcCtD
Omeprazole—Constipation—Lisinopril—dilated cardiomyopathy	0.000709	0.00153	CcSEcCtD
Omeprazole—Vomiting—Furosemide—dilated cardiomyopathy	0.000703	0.00151	CcSEcCtD
Omeprazole—Rash—Furosemide—dilated cardiomyopathy	0.000697	0.0015	CcSEcCtD
Omeprazole—Dermatitis—Furosemide—dilated cardiomyopathy	0.000696	0.0015	CcSEcCtD
Omeprazole—Headache—Furosemide—dilated cardiomyopathy	0.000693	0.00149	CcSEcCtD
Omeprazole—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000683	0.00147	CcSEcCtD
Omeprazole—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000678	0.00146	CcSEcCtD
Omeprazole—Urticaria—Lisinopril—dilated cardiomyopathy	0.000659	0.00142	CcSEcCtD
Omeprazole—Nausea—Furosemide—dilated cardiomyopathy	0.000657	0.00141	CcSEcCtD
Omeprazole—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000656	0.00141	CcSEcCtD
Omeprazole—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000656	0.00141	CcSEcCtD
Omeprazole—ATP4B—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000626	0.0148	CbGpPWpGaD
Omeprazole—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000611	0.00132	CcSEcCtD
Omeprazole—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000609	0.0144	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000609	0.0144	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000609	0.0144	CbGpPWpGaD
Omeprazole—Asthenia—Lisinopril—dilated cardiomyopathy	0.000595	0.00128	CcSEcCtD
Omeprazole—Pruritus—Lisinopril—dilated cardiomyopathy	0.000587	0.00126	CcSEcCtD
Omeprazole—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000567	0.00122	CcSEcCtD
Omeprazole—ATP4B—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000566	0.0134	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000558	0.0132	CbGpPWpGaD
Omeprazole—Dizziness—Lisinopril—dilated cardiomyopathy	0.000548	0.00118	CcSEcCtD
Omeprazole—ATP4A—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000543	0.0129	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000543	0.0129	CbGpPWpGaD
Omeprazole—Vomiting—Lisinopril—dilated cardiomyopathy	0.000527	0.00114	CcSEcCtD
Omeprazole—Rash—Lisinopril—dilated cardiomyopathy	0.000523	0.00113	CcSEcCtD
Omeprazole—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000522	0.00113	CcSEcCtD
Omeprazole—Headache—Lisinopril—dilated cardiomyopathy	0.00052	0.00112	CcSEcCtD
Omeprazole—ATP4A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000505	0.012	CbGpPWpGaD
Omeprazole—Nausea—Lisinopril—dilated cardiomyopathy	0.000493	0.00106	CcSEcCtD
Omeprazole—CYP1A1—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.000484	0.0115	CbGpPWpGaD
Omeprazole—CYP1A1—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000474	0.0112	CbGpPWpGaD
Omeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.000474	0.0112	CbGpPWpGaD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—GJA1—dilated cardiomyopathy	0.000396	0.00938	CbGpPWpGaD
Omeprazole—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000388	0.0092	CbGpPWpGaD
Omeprazole—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000357	0.00846	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000355	0.00842	CbGpPWpGaD
Omeprazole—ATP4B—Ion channel transport—RAF1—dilated cardiomyopathy	0.000355	0.00841	CbGpPWpGaD
Omeprazole—CYP1B1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000341	0.00809	CbGpPWpGaD
Omeprazole—CYP1A1—Oxidative Stress—SOD2—dilated cardiomyopathy	0.000332	0.00786	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000331	0.00785	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.000327	0.00774	CbGpPWpGaD
Omeprazole—CYP1A1—Oxidative Stress—GPX1—dilated cardiomyopathy	0.000316	0.0075	CbGpPWpGaD
Omeprazole—ATP4A—Ion channel transport—RAF1—dilated cardiomyopathy	0.000316	0.00749	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000311	0.00738	CbGpPWpGaD
Omeprazole—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000302	0.00717	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000279	0.00661	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000262	0.00621	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000222	0.00526	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000219	0.00519	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000211	0.00501	CbGpPWpGaD
Omeprazole—CYP1A1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00021	0.00498	CbGpPWpGaD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.0002	0.00474	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000199	0.00471	CbGpPWpGaD
Omeprazole—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000193	0.00457	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000189	0.00448	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000184	0.00435	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000184	0.00435	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000172	0.00409	CbGpPWpGaD
Omeprazole—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000172	0.00408	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000171	0.00405	CbGpPWpGaD
Omeprazole—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000157	0.00372	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000152	0.00361	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000152	0.00361	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000147	0.0035	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000145	0.00344	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000145	0.00344	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000145	0.00344	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00014	0.00331	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—TAZ—dilated cardiomyopathy	0.000139	0.00329	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000137	0.00324	CbGpPWpGaD
Omeprazole—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000134	0.00318	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00013	0.00309	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00013	0.00308	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—ANKRD1—dilated cardiomyopathy	0.000128	0.00302	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000127	0.003	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000127	0.003	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—SDHA—dilated cardiomyopathy	0.000125	0.00297	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000124	0.00294	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000123	0.00293	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000122	0.0029	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000122	0.00288	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—TAZ—dilated cardiomyopathy	0.00012	0.00284	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000119	0.00283	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000118	0.00279	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—TAZ—dilated cardiomyopathy	0.000117	0.00277	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000113	0.00268	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000112	0.00266	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00011	0.00261	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000109	0.00258	CbGpPWpGaD
Omeprazole—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000109	0.00258	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—SDHA—dilated cardiomyopathy	0.000109	0.00257	CbGpPWpGaD
Omeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000107	0.00253	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000106	0.00252	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—SDHA—dilated cardiomyopathy	0.000106	0.0025	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.0001	0.00237	CbGpPWpGaD
Omeprazole—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	9.81e-05	0.00233	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	9.71e-05	0.0023	CbGpPWpGaD
Omeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	9.6e-05	0.00228	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ANKRD1—dilated cardiomyopathy	9.41e-05	0.00223	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	9.38e-05	0.00222	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	9.38e-05	0.00222	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.13e-05	0.00216	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	8.93e-05	0.00212	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	8.93e-05	0.00212	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—TAZ—dilated cardiomyopathy	8.85e-05	0.0021	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	8.72e-05	0.00207	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	8.56e-05	0.00203	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.3e-05	0.00197	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	8.05e-05	0.00191	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—SDHA—dilated cardiomyopathy	8e-05	0.0019	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.8e-05	0.00185	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.65e-05	0.00181	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.45e-05	0.00177	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	7.35e-05	0.00174	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	7.28e-05	0.00172	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.04e-05	0.00167	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.85e-05	0.00162	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.85e-05	0.00162	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.71e-05	0.00159	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	6.62e-05	0.00157	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.44e-05	0.00153	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.37e-05	0.00151	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.27e-05	0.00149	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	5.98e-05	0.00142	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	5.98e-05	0.00142	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	5.79e-05	0.00137	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	5.7e-05	0.00135	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	5.7e-05	0.00135	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.65e-05	0.00134	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	5.58e-05	0.00132	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	5.45e-05	0.00129	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	5.38e-05	0.00128	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	5.31e-05	0.00126	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	5.28e-05	0.00125	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	4.99e-05	0.00118	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	4.93e-05	0.00117	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.88e-05	0.00116	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.75e-05	0.00113	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	4.74e-05	0.00112	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	4.63e-05	0.0011	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	4.63e-05	0.0011	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	4.52e-05	0.00107	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	4.46e-05	0.00106	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	4.36e-05	0.00103	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	4.35e-05	0.00103	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	4.32e-05	0.00102	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.28e-05	0.00101	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	4.1e-05	0.000972	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	4.06e-05	0.000963	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	4.03e-05	0.000955	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	3.93e-05	0.000933	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.73e-05	0.000883	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	3.71e-05	0.000879	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	3.69e-05	0.000876	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	3.68e-05	0.000871	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.5e-05	0.000829	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	3.47e-05	0.000823	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—GPX1—dilated cardiomyopathy	3.41e-05	0.000807	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CD36—dilated cardiomyopathy	3.32e-05	0.000786	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	3.14e-05	0.000744	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3e-05	0.000712	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AGT—dilated cardiomyopathy	2.99e-05	0.000708	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—GPX1—dilated cardiomyopathy	2.95e-05	0.000699	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.93e-05	0.000694	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CD36—dilated cardiomyopathy	2.87e-05	0.00068	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—GPX1—dilated cardiomyopathy	2.87e-05	0.00068	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.85e-05	0.000676	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CD36—dilated cardiomyopathy	2.79e-05	0.000662	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.75e-05	0.000653	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.68e-05	0.000636	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.68e-05	0.000635	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.63e-05	0.000625	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AGT—dilated cardiomyopathy	2.58e-05	0.000613	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.57e-05	0.000609	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AGT—dilated cardiomyopathy	2.51e-05	0.000596	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.46e-05	0.000583	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.42e-05	0.000575	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.42e-05	0.000573	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.4e-05	0.000568	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.39e-05	0.000568	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.28e-05	0.000541	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.24e-05	0.000531	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.18e-05	0.000518	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GPX1—dilated cardiomyopathy	2.17e-05	0.000515	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.16e-05	0.000511	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CD36—dilated cardiomyopathy	2.12e-05	0.000502	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	1.98e-05	0.000469	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.97e-05	0.000466	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CD36—dilated cardiomyopathy	1.93e-05	0.000456	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.92e-05	0.000454	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AGT—dilated cardiomyopathy	1.91e-05	0.000452	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.87e-05	0.000442	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AGT—dilated cardiomyopathy	1.73e-05	0.000411	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.68e-05	0.000398	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.39e-05	0.000329	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	1.34e-05	0.000317	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	1.3e-05	0.000309	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	1.23e-05	0.000291	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	1.19e-05	0.000283	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	1.17e-05	0.000278	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.1e-05	0.00026	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	1.08e-05	0.000255	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.07e-05	0.000253	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1.07e-05	0.000253	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.04e-05	0.000247	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.01e-05	0.000239	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	9.99e-06	0.000237	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	9.81e-06	0.000232	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	9.72e-06	0.00023	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	9.6e-06	0.000228	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AGT—dilated cardiomyopathy	9.37e-06	0.000222	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	8.83e-06	0.000209	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	8.76e-06	0.000208	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	8.53e-06	0.000202	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	8.31e-06	0.000197	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	7.48e-06	0.000177	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	6.59e-06	0.000156	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	6.41e-06	0.000152	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.77e-06	0.000137	CbGpPWpGaD
